Protein kinase C isozymes as regulators of sensitivity to and self-administration of drugs of abuse-studies with genetically modified mice

Behavioural Pharmacology

Volumn 21, Issue 5-6, 2010, Pages 493-499

  Olive, Michael Foster ^a   Newton, Philip M ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

cannabinoids; ethanol; isozymes; morphine; mouse; protein kinase C; targeted gene deletion

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; AMPHETAMINE; BENZODIAZEPINE; ELTANOLONE; FLUNITRAZEPAM; ISOENZYME; LY 379196; MORPHINE; NICOTINE; OPIATE; PENTOBARBITAL; PROTEIN KINASE C; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA INHIBITOR; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C GAMMA; PROTEIN KINASE C INHIBITOR; PSYCHOSTIMULANT AGENT; RUBOXISTAURIN;

CLINICAL TRIAL; COMPETITIVE INHIBITION; DIABETIC RETINOPATHY; DNA MODIFICATION; DRUG ABUSE; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; DRUG SENSITIVITY; GENE DELETION; HUMAN; LONG TERM POTENTIATION; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SUBSTANCE ABUSE;

ANIMALS; BEHAVIOR, ADDICTIVE; ENZYME INHIBITORS; GENE DELETION; HUMANS; ISOENZYMES; MICE; PROTEIN KINASE C; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 77955959096     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32833d8bb7     Document Type: Review

References (70)

1. Abeliovich A, Chen C, Goda Y, Silva AJ, Stevens CF, Tonegawa S (1993a). Modified hippocampal long-term potentiation in PKC gamma-mutant mice. Cell 75:1253-1262.
2. Abeliovich A, Paylor R, Chen C, Kim JJ, Wehner JM, Tonegawa S (1993b). PKC gamma mutant mice exhibit mild deficits in spatial and contextual learning. Cell 75:1263-1271.
3. Aksoy E, Goldman M, Willems F (2004). Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. Int J Biochem Cell Biol 36:183-188.
4. Basu A, Sivaprasad U (2007). Protein kinase C epsilon makes the life and death decision. Cell Signal 19:1633-1642.
5. Bowers BJ, Wehner JM (2001). Ethanol consumption and behavioral impulsivity are increased in protein kinase Cg null mutant mice. J Neurosci 21:181-185.
6. Bowers BJ, Owen EH, Collins AC, Abeliovich A, Tonegawa S, Wehner JS (1999). Decreased ethanol sensitivity and tolerance development in g-protein kinase C null mutant mice is dependent on genetic background. Alcohol Clin Exp Res 23:387-397.
7. Bowers BJ, Collins AC, Wehner JM (2000). Background genotype modulates the effects of gamma-PKC on the development of rapid tolerance to ethanol-induced hypothermia. Addict Biol 5:47-58.
8. Browman KE, Kantor L, Richardson S, Badiani A, Robinson TE, Gnegy ME (1998). Injection of the protein kinase C inhibitor Ro31-8220 into the nucleus accumbens attenuates the acute response to amphetamine: tissue and behavioral studies. Brain Res 814:112-119.
9. Busquets X, Escriba PV, Sastre M, Garcia-Sevilla JA (1995). Loss of protein kinase C-alpha beta in brain of heroin addicts and morphine-dependent rats. J Neurochem 64:247-252.
10. Celerier E, Simonnet G, Maldonado R (2004). Prevention of fentanyl-induced delayed pronociceptive effects in mice lacking the protein kinase Cg gene. Neuropharmacology 46:264-272.
11. Chen R, Furman CA, Zhang M, Kim MN, Gereau RW, Leitges M, Gnegy ME (2009). Protein kinase Cg is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice. J Pharmacol Exp Ther 328:912-920.
12. Choi DS, Messing RO (2003). Animal models in the study of protein kinase C isozymes. Methods Mol Biol 233:455-473.
13. Choi DS, Wang D, Dadgar J, Chang WS, Messing RO (2002). Conditional rescue of protein kinase C e regulates ethanol preference and hypnotic sensitivity in adult mice. J Neurosci 22:9905-9911.
14. Choi DS, Wei W, Deitchman JK, Kharazia VN, Lesscher HM, McMahon T, et al. (2008). Protein kinase Cd regulates ethanol intoxication and enhancement of GABA-stimulated tonic current. J Neurosci 28:11890-11899.
15. Churchill E, Budas G, Vallentin A, Koyanagi T, Mochly-Rosen D (2008). PKC isozymes in chronic cardiac disease: possible therapeutic targets? Annu Rev Pharmacol Toxicol 48:569-599.
16. Crews FT, Boettiger CA (2009). Impulsivity, frontal lobes and risk for addiction. Pharmacol Biochem Behav 93:237-247.
17. Danis RP, Sheetz MJ (2009). Ruboxistaurin: PKC-beta inhibition for complications of diabetes. Expert Opin Pharmacother 10:2913-2925.
18. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, et al. (2004). Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 (Suppl 1):227-241.
19. Everitt BJ, Belin D, Economidou D, Pelloux Y, Dalley JW, Robbins TW (2008). Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 363:3125-3135.
20. Garcia-Sevilla JA, Ventayol P, Busquets X, La Harpe R, Walzer C, Guimon J (1997). Regulation of immunolabelled mu-opioid receptors and protein kinase C-alpha and zeta isoforms in the frontal cortex of human opiate addicts. Neurosci Lett 226:29-32.
21. Gass JT, Olive MF (2009). Role of protein kinase Ce (PKCe) in the reduction of ethanol reinforcement due to mGluR5 antagonism in the nucleus accumbens shell. Psychopharmacology (Berl) 204:587-597.
22. Gorin MA, Pan Q (2009). Protein kinase C epsilon: an oncogene and emerging tumor biomarker. Mol Cancer 8:9.
23. Harris RA, McQuilkin SJ, Paylor R, Abeliovich A, Tonegawa S, Wehner JM (1995). Mutant mice lacking the gamma isoform of protein kinase C show decreased behavioral actions of ethanol and altered function of gamma-aminobutyrate type A receptors. Proc Natl Acad Sci\USA 92:3658-3662.
24. Hirai T, Chida K (2003). Protein kinase C zeta (PKCB): activation mechanisms and cellular functions. J Biochem 133:1-7.
25. Hodge CW, Mehmert KK, Kelley SP, McMahon T, Haywood A, Olive MF, et al. (1999). Supersensitivity to allosteric GABAA receptor modulators and alcohol in mice lacking PKCe. Nat Neurosci 2:997-1002.
26. Hodge CW, Raber J, McMahon T, Walter H, Sanchez-Perez AM, Olive MF, et al. (2002). Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Ce. J Clin Invest 110:1003-1010.
27. Hodgkinson CA, Yuan Q, Xu K, Shen PH, Heinz E, Lobos EA, et al. (2008). Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43:505-515.
28. Huang FL, Yoshida Y, Nakabayashi H, Young WS III, Huang KP (1988). Immunocytochemical localization of protein kinase C isozymes in rat brain. J Neurosci 8:4734-4744.
29. Jiang ZL, Ye J-H (2003). Protein kinase Ce is involved in ethanol potentiation of glycine-gated Cl-current in rat neurons of ventral tegmental area. Neuropharmacology 44:493-502.
30. Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald JH III, Neel DA, et al. (1996). (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexade-cene- 1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta. J Med Chem 39:2664-2671.
31. Johnson LA, Guptaroy B, Lund D, Shamban S, Gnegy ME (2005). Regulation of amphetamine-stimulated dopamine efflux by protein kinase C b. J Biol Chem 280:10914-10919.
32. Kawakami T, Kawakami Y, Kitaura J (2002). Protein kinase C b (PKC b): normal functions and diseases. J Biochem 132:677-682.
33. Khasar SG, Lin Y-H, Martin A, Dadgar J, McMahon T, Wang D, et al. (1999). A novel nociceptor signaling pathway demonstrated in protein kinase Ce mutant mice. Neuron 24:253-260.
34. Koob GF, Volkow ND (2010). Neurocircuitry of addiction. Neuropsychopharma-cology 35:217-238.
35. Kumar S, Sieghart W, Morrow AL (2002). Association of protein kinase C with GABAA receptors containing a1 and a4 subunits in the cerebral cortex: selective effects of chronic ethanol consumption. J Neurochem 82:110-117.
36. Lee AM, Messing RO (2008). Protein kinases and addiction. Ann N Y Acad Sci 1141:22-57.
37. Lesscher HM, McMahon T, Lasek AW, Chou WH, Connolly J, Kharazia V, Messing RO (2008). Amygdala protein kinase C epsilon regulates corticotropin-releasing factor and anxiety-like behavior. Genes Brain Behav 7:323-333.
38. Lesscher HMB, Wallace MJ, Zeng L, Wang V, Deitchman JK, McMahon T, et al. (2009). Amygdala protein kinase C epsilon controls alcohol consumption. Genes Brain Behav 8:493-499.
39. Mellor H, Parker PJ (1998). The extended protein kinase C superfamily. Biochem J 332 (Pt 2):281-292.
40. Messing RO, Petersen PJ, Henrich CJ (1991). Chronic ethanol exposure increases levels of protein kinase C delta and epsilon and protein kinase C-mediated phosphorylation in cultured neural cells. J Biol Chem 266:23428-23432.
41. Minami H, Owada Y, Handa Y, Kondo H (2001). Localization of mRNAs for novel, atypical as well as conventional protein kinase C (PKC) isoforms in the brain of developing and mature rats. J Mol Neurosci 15:121-135.
42. Mulligan MK, Ponomarev I, Hitzemann RJ, Belknap JK,Tabakoff B, Harris RA, et al. (2006). Toward understanding the genetics of alcohol drinking through transcriptome meta-analysis. Proc Natl Acad Sci\USA 103:6368-6373.
43. Naik MU, Benedikz E, Hernandez I, Libien J, Hrabe J, Valsamis M, et al. (2000). Distribution of protein kinase MB and the complete protein kinase C isoform family in rat brain. J Comp Neurol 426:243-258.
44. Narita M, Aoki T, Ozaki S, Yajima Y, Suzuki T (2001a). Involvement of protein kinase Cg isoform in morphine-induced reinforcing effects. Neuroscience 103:309-314.
45. Narita M, Mizoguchi H, Suzuki T, Dun NJ, Imai S, Yajima Y, et al. (2001b). Enhanced mu-opioid responses in the spinal cord of mice lacking protein kinase Cg isoform. J Biol Chem 276:15409-15414.
46. Narita M, Tamaki H, Kobayashi M, Soma M, Suzuki T (2001c). Changes in Ca(2 +)-dependent protein kinase C isoforms induced by chronic ethanol treatment in mice. Neurosci Lett 307:85-88.
47. Narita M, Akai H, Nagumo Y, Sunagawa N, Hasebe K, Nagase H, et al. (2004). Implications of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats. Neuroscience 127:941-948.
48. Newton PM, Messing RO (2006). Intracellular signaling pathways that regulate behavioral responses to ethanol. Pharmacol Ther 109:227-237.
49. Newton PM, Messing RO (2007). Increased sensitivity to the aversive effects of ethanol in PKCe null mice revealed by place conditioning. Behav Neurosci 121:439-442.
50. Newton PM, Ron D (2007). Protein kinase C and alcohol addiction. Pharmacol Res 55:570-577.
51. Newton PM, Messing RO (2010). The substrates and binding partners of protein kinase Ce. Biochem J 427:189-196.
52. Newton PM, Kim JA, McGeehan AJ, Paredes JP, Chu K, Wallace MJ, et al. (2007). Increased response to morphine in mice lacking protein kinase C epsilon. Genes Brain Behav 6:329-338.
53. Nishizuka Y (1988). The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334:661-665.
54. Olive MF, Ron D (2003). Alcohol addiction. Methods Mol Biol 233:555-570.
55. Olive MF, Messing RO (2004). Protein kinase C isozymes and addiction. Mol Neurobiol 29:139-153.
56. Olive MF, Mehmert KK, Messing RO, Hodge CW (2000). Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCe deficient mice. Eur J Neurosci 12:4131-4140.
57. Olive MF, Mehmert KK, Nannini MA, Camarini R, Messing RO, Hodge CW (2001). Reduced ethanol withdrawal severity and altered withdrawal-induced c-fos expression in various brain regions of mice lacking protein kinase C-epsilon. Neuroscience 103:171-179.
58. Proctor WR, Poelchen W, Bowers BJ, Wehner JM, Messing RO, Dunwiddie TV (2003). Ethanol differentially enhances hippocampal GABAA receptor-mediated responses in protein kinase Cg (PKCg) and PKCe null mice. J Pharmacol Exp Ther 305:264-270.
59. Qi ZH, Song M, Wallace MJ, Wang D, Newton PM, McMahon T, et al. (2007). Protein kinase Ce regulates g-aminobutyrate type A receptor sensitivity to ethanol and benzodiazepines through phosphorylation of g2 subunits. J Biol Chem 282:33052-33063.
60. Reyland ME (2007). Protein kinase Cd and apoptosis. Biochem Soc Trans 35:1001-1004.
61. Rodd ZA, Kimpel MW, Edenberg HJ, Bell RL, Strother WN, McClintick JN, et al. (2008). Differential gene expression in the nucleus accumbens with ethanol self-administration in inbred alcohol-preferring rats. Pharmacol Biochem Behav 89:481-498.
62. Rykx A, De Kimpe L, Mikhalap S, Vantus T, Seufferlein T, Vandenheede JR, Van Lint J (2003). Protein kinase D: a family affair. FEBS Lett 546:81-86.
63. Song M, Messing RO (2005). Protein kinase C regulation of GABAA receptors. Cell Mol Life Sci 62:119-127.
64. Tanaka C, Saito N (1992). Localization of subspecies of protein kinase C in the mammalian central nervous system. Neurochem Int 21:499-512.
65. Wallace MJ, Newton PM, Oyasu M, McMahon T, Chou WH, Connolly J, Messing RO (2007). Acute functional tolerance to ethanol mediated by protein kinase Ce. Neuropsychopharmacology 32:127-136.
66. Wallace MJ, Newton PM, McMahon T, Connolly J, Huibers A, Whistler J, Messing RO (2009). PKCe regulates behavioral sensitivity, binding and tolerance to the CB1 receptor agonist WIN55,212-2. Neuropsychopharmacology 34:1733-1742.
67. Wise RA (2004). Dopamine, learning and motivation. Nat Rev Neurosci 5:483-494.
68. Yonezawa T, Kurata R, Kimura M, Inoko H (2009). PKC delta and epsilon in drug targeting and therapeutics. Recent Pat DNA Gene Seq 3:96-101.
69. Young WSD (1988). Expression of three (and a putative four) protein kinase C genes in brains of rat and rabbit. J Chem Neuroanat 1:177-194.
70. Zhang D, Kanthasamy A, Yang Y, Anantharam V (2007). Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons. J Neurosci 27:5349-5362.